TMEM2 inhibits hepatitis B virus infection in HepG2 and HepG2.2.15 cells by activating the JAK–STAT signaling pathway
Cell Death and Disease 7, e2239 (June 2016). doi:10.1038/cddis.2016.146
Authors: X Zhu, C Xie, Y-m Li, Z-l Huang, Q-y Zhao, Z-x Hu, P-p Wang, Y-r Gu, Z-l Gao & L Peng
from #MedicinebyAlexandrosSfakianakis via xlomafota13 on Inoreader http://ift.tt/1XkZMmO
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου